Related references
Note: Only part of the references are listed.Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ
G. Fousteri et al.
DIABETOLOGIA (2010)
Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence
Woelsung Yi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
CXCL12 enhances exogenous CD4+CD25+ T cell migration and prevents embryo loss in non-obese diabetic mice
Yi Lin et al.
FERTILITY AND STERILITY (2009)
Systemic Correction of Storage Disease in MPS I NOD/SCID Mice Using the Sleeping Beauty Transposon System
Elena L. Aronovich et al.
MOLECULAR THERAPY (2009)
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
Meghan A. Koch et al.
NATURE IMMUNOLOGY (2009)
Prevention of embryo loss in non-obese diabetic mice using adoptive ITGA2+ISG20+ natural killer-cell transfer
Yi Lin et al.
REPRODUCTION (2009)
Anti-inflammatory effects of FTY720 against viral-induced immunopathology:: Role of drug-induced conversion of T cells to become Foxp3+ regulators
Sharvan Sehrawat et al.
JOURNAL OF IMMUNOLOGY (2008)
The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors
Anna Morena D'Alise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3- precursors
Sayuri Yamazaki et al.
BLOOD (2007)
Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes
Markus Feuerer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid
Cheng-Ming Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
Volker Brinkmann
PHARMACOLOGY & THERAPEUTICS (2007)
Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells
Richard J. Mellanby et al.
IMMUNOLOGY (2007)
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells
Carolin Daniel et al.
JOURNAL OF IMMUNOLOGY (2007)
The immunosuppressant drug FTY720 inhibits cytosohc phospholipase A2 independently of sphingosine-1-phosphate receptors
Shawn G. Payne et al.
BLOOD (2007)
Regulatory T-cell physiology and application to treat autoimmunity
Qizhi Tang et al.
IMMUNOLOGICAL REVIEWS (2006)
Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+ CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice
Pascale Alard et al.
DIABETES (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
TLR3-involved modulation of pregnancy tolerance in double-stranded RNA-stimulated NOD/SCID mice
Yi Lin et al.
JOURNAL OF IMMUNOLOGY (2006)
The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells
CY Xin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity
E Sawicka et al.
JOURNAL OF IMMUNOLOGY (2005)
Inducing and expanding regulatory T cell populations by foreign antigen
K Kretschmer et al.
NATURE IMMUNOLOGY (2005)
Essential role for CD103 in the T cell-mediated regulation of experimental colitis
O Annacker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes
SM Pop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulatory T cell lineage specification by the forkhead transcription factor FoxP3
JD Fontenot et al.
IMMUNITY (2005)
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells
H Müller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
CD4+ CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions
S Suvas et al.
JOURNAL OF IMMUNOLOGY (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses
CY Xin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Absence of lymph nodes in NOD mice treated with lymphotoxin-β receptor immunoglobulin protects from diabetes
MG Levisetti et al.
DIABETES (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development
S Gregori et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumor necrosis factor-a regulation of CD4+C25+ T cell levels in NOD mice
AJ Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Generation of CD4+CD25+ regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression
K Kawahata et al.
JOURNAL OF IMMUNOLOGY (2002)
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes
B Salomon et al.
IMMUNITY (2000)